Abstract 6273: CTS3157, a novel MTA-cooperative PRMT5 inhibitor for targeting <i>MTAP</i>-deleted human tumors
Long Wang(The University of Texas at San Antonio Health Science Center), Haiping Wu(Chongqing Medical University), Youzhen Wang(Novartis (China)), Qiugeng Ouyang, Yuanyuan Liu(Sun Yat-sen University), Guoliang Xu(Chinese Academy of Sciences), Jiannan Guo(University of Washington), Yuan Mi(Fourth Hospital of Hebei Medical University), Yiqin Wang(Shanghai Medical College of Fudan University), Yilin Liu(Hunan University of Science and Technology), Hui Shi(Shanghai Jiao Tong University)
Cited by 2
Related Papers
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
|Nature Medicine|2015|1.4k
Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3
|Molecular Cancer|2019|647
An All‐Solid‐State Flexible Micro‐supercapacitor on a Chip
|Advanced Energy Materials|2011|377
A Huntingtin Knockin Pig Model Recapitulates Features of Selective Neurodegeneration in Huntington’s Disease
|Cell|2018|345
Developmental relationships between adolescent substance use and risky sexual behavior in young adulthood
|Journal of Adolescent Health|2002|289